BioReference Laboratories Announces NextGen Sequencing for Dilated Cardiomyopathy Testing
BioReference Laboratories Inc announces that it is now offering next generation sequencing testing for Dilated Cardiomyopathy (DCM) conditions through its GeneDx laboratory.
Read More